I am a rheumatologist and epidemiologist whose research has focused primarily on risk factors for knee osteoarthritis and gout, pain mechanisms in knee osteoarthritis, as well as methodologic issues of relevance for rheumatic diseases. I have had continuous peer-reviewed foundation and NIH funding since 2003, and have over 170 peer-reviewed publications to date. I am the most recent past chair of the FDA Arthritis Advisory Committee, serve on the boards two international societies: Osteoarthritis Research Society International (OARSI) and Gout, Hyperuricemia, and Crystal-Associated Diseases Network (G-CAN), and on committees for the American College of Rheumatology (ACR) and International Association for the Study Pain (IASP), among others. My work has been recognized with the prestigious 2014 ACR Henry Kunkel Young Investigator Award for outstanding and promising independent contributions to rheumatology research (awarded to no more than one clinical researcher and/or one basic science researcher each year). I have also engaged in developing new classification criteria for a number of rheumatic diseases. In addition to research, clinical work, and teaching, one of my key roles is to mentor trainees and junior faculty in musculoskeletal disease-related research. To that end, I was awarded the 2016 Robert Dawson Evans Research Mentoring Award. I am also leading the new CTSI Research Career Support Program initiative, PRIME (Pathways to Research Independence and Mentoring Excellence), which aims to support early career mentored researchers to successfully transition to becoming independent researchers.
– Osteoarthritis: epidemiology; risk factors; mechanisms of osteoarthritis-related pain; the role of bone in the pathophysiology of osteoarthritis
– Gout: epidemiology; risk factors and triggers for gout attacks; management of gout; consequences of gout and hyperuricemia
– Classification criteria and outcome measures in rheumatic diseases.
– Novel methodology to address challenging epidemiologic issues
- Professor, Epidemiology, Boston University School of Public Health
- Attending Physician, Rheumatology (Arthritis), Medicine, Boston Medical Center
- University of Toronto, MD
- Boston University School of Public Health, PhD
- McMaster University, BS
- Published on 6/22/2018
Cohen EM, Edwards RR, Bingham CO, Phillips K, Bolster MB, Moreland LW, Neogi T, Marder W, Wohlfahrt A, Clauw D, Lee YC. Pain and Catastrophizing in Patients With Rheumatoid Arthritis: A Prospective Observational Cohort Study. J Clin Rheumatol. 2018 Jun 22. PMID: 30035754.
- Published on 6/16/2018
Dubreuil M, Louie-Gao Q, Peloquin C, Choi HK, Zhang Y, Neogi T. Response to: 'Association between use of non-steroidal anti-inflammatory drugs and risk of myocardial infarction in patients with spondyloarthritis and osteoarthritis'. Ann Rheum Dis. 2018 Jun 16. PMID: 29909375.
- Published on 6/13/2018
Zhang M, Solomon DH, Desai RJ, Kang EH, Liu J, Neogi T, Kim SC. Assessment of Cardiovascular Risk in Older Patients with Gout Initiating Febuxostat versus Allopurinol: A Population-Based Cohort Study. Circulation. 2018 Jun 13. PMID: 29899013.
- Published on 6/8/2018
Wohlfahrt A, Bingham CO, Marder W, Phillips K, Bolster MB, Moreland LW, Zhang Z, Neogi T, Lee YC. Responsiveness of Patient Reported Outcomes Measurement Information System (PROMIS) Measures in RA Patients Starting or Switching a DMARD. Arthritis Care Res (Hoboken). 2018 Jun 08. PMID: 29885039.
- Published on 6/5/2018
Choi H, Neogi T, Stamp L, Dalbeth N, Terkeltaub R. Implications of the cardiovascular safety of febuxostat and allopurinol in patients with gout and cardiovascular morbidities (CARES) trial and associated FDA public safety alert. Arthritis Rheumatol. 2018 Jun 05. PMID: 29869840.
- Published on 5/2/2018
Fenton SAM, Neogi T, Dunlop D, Nevitt M, Doherty M, Duda JL, Klocke R, Abhishek A, Rushton A, Zhang W, Lewis CE, Torner J, Kitas G, White DK. Does the intensity of daily walking matter for protecting against the development of a slow gait speed in people with or at high risk of knee osteoarthritis? An observational study. Osteoarthritis Cartilage. 2018 May 02. PMID: 29729332.
- Published on 4/19/2018
Dubreuil M, Louie-Gao Q, Peloquin CE, Choi HK, Zhang Y, Neogi T. Risk of myocardial infarction with use of selected non-steroidal anti-inflammatory drugs in patients with spondyloarthritis and osteoarthritis. Ann Rheum Dis. 2018 Aug; 77(8):1137-1142. PMID: 29674321.
- Published on 4/12/2018
FitzGerald JD, Mikuls TR, Neogi T, Singh JA, Robbins M, Khanna PP, Turner AS, Myslinski R, Suter LG. Development of the American College of Rheumatology Electronic Clinical Quality Measures for Gout. Arthritis Care Res (Hoboken). 2018 May; 70(5):659-671. PMID: 29649348.
- Published on 4/2/2018
Abhishek A, Neogi T, Choi H, Doherty M, Rosenthal AK, Terkeltaub R. Unmet Needs and the Path Forward in Joint Disease Associated With Calcium Pyrophosphate Crystal Deposition. Arthritis Rheumatol. 2018 Apr 02. PMID: 29609209.
- Published on 4/2/2018
Felson DT, Neogi T. Challenges for Osteoarthritis Trials. Arthritis Rheumatol. 2018 Apr 02. PMID: 29609224.
View 181 more publications: View full profile at BUMC